EMILY M MILLER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BUTLER, NJ NPI 1104283431

General Payments — all program years on this page

$1,254.54

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 38
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $510.17 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $486.2918
Education $23.883

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $293.629
ABBVIE INC. $54.163
Acerta Pharma LLC $49.793
PFIZER INC. $34.722
NOVARTIS PHARMACEUTICALS CORPORATION $33.321
DePuy Synthes Sales Inc. $17.511
UCB, Inc. $13.791
GlaxoSmithKline, LLC. $13.261

By program year

Program yearAmountRecords
2021 $16.241
2022 $243.122
2023 $485.0114
2024 $510.1721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077870854 DePuy Synthes Sales Inc. $17.51 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086990634 Novartis Pharmaceuticals Corporation $33.32 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105574874 AstraZeneca Pharmaceuticals LP $19.93 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105727305 AstraZeneca Pharmaceuticals LP $14.93 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105849262 AstraZeneca Pharmaceuticals LP $14.93 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107663832 ABBVIE INC. $19.33 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107663834 ABBVIE INC. $17.83 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107663836 ABBVIE INC. $17.00 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115932265 Amgen Inc. $96.55 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115932269 Amgen Inc. $118.39 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115932309 Amgen Inc. $10.69 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115932321 Amgen Inc. $15.83 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115932425 Amgen Inc. $11.22 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116130240 GlaxoSmithKline, LLC. $13.26 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117630787 Amgen Inc. $7.96 08/15/2024 Education Undisputed 01/23/2026 View at CMS
1117630789 Amgen Inc. $7.96 08/15/2024 Education Undisputed 01/23/2026 View at CMS
1117630791 Amgen Inc. $7.96 08/15/2024 Education Undisputed 01/23/2026 View at CMS
1117630793 Amgen Inc. $17.06 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131189909 PFIZER INC. $15.75 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132077555 PFIZER INC. $18.97 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143454757 UCB, Inc. $13.79 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.